Cytokine and Growth Factor Bioassays

The VEGF Bioassay is a bioluminescent cell-based assay that measures VEGF stimulation and inhibition of KDR (VEGFR-2) using NFAT-RE as a readout. T...

The VEGF Bioassay is a bioluminescent cell-based assay that measures VEGF stimulation and inhibition of KDR (VEGFR-2) using NFAT-RE as a readout. T...

The VEGF Bioassay is a bioluminescent cell-based assay that measures VEGF stimulation and inhibition of KDR (VEGFR-2) using NFAT-RE as a readout. T...

Recombinant VEGF may be used as a positive control ligand in the VEGF Bioassay (Cat.# GA2001, GA2005). Human VEGF-165, amino acids Ala27-Arg191 (Ac...

Receptor activator of nuclear factor-κB (NF-κB; RANK/TRANCE receptor/TNFRSF11A) is a member of the tumor necrosis factor receptor (TNFR) family. Bi...

Receptor activator of nuclear factor-κB (NF-κB; RANK/TRANCE receptor/TNFRSF11A) is a member of the tumor necrosis factor receptor (TNFR) family. Bi...

Receptor activator of nuclear factor-κB (NF-κB; RANK/TRANCE receptor/TNFRSF11A) is a member of the tumor necrosis factor receptor (TNFR) family. Bi...

Interleukin-6 (IL-6, originally termed BCDF/BSF2) was first identified in 1983 alongside molecules with similar but distinct functional properties ...

Interleukin-6 (IL-6, originally termed BCDF/BSF2) was first identified in 1983 alongside molecules with similar but distinct functional properties ...

Interleukin-6 (IL-6, originally termed BCDF/BSF2) was first identified in 1983 alongside molecules with similar but distinct functional properties ...

Interleukin-23 (IL-23) was first described in 2000 when a computational screen identified a novel sequence (p19) that combined with the p40 subunit...

Interleukin-23 (IL-23) was first described in 2000 when a computational screen identified a novel sequence (p19) that combined with the p40 subunit...

Interleukin-23 (IL-23) was first described in 2000 when a computational screen identified a novel sequence (p19) that combined with the p40 subunit...

The IL-2 Bioassay is a bioluminescent cell-based assay designed to measure IL-2 stimulation or inhibition. The IL-2 Bioassay Cells are provided in ...

The IL-2 Bioassay is a bioluminescent cell-based assay designed to measure IL-2 stimulation or inhibition. The IL-2 Bioassay Cells are provided in ...

The IL-2 Bioassay is a bioluminescent cell-based assay designed to measure IL-2 stimulation or inhibition. The IL-2 Bioassay Cells are provided in ...

The IL-15 Bioassay is a bioluminescent cell-based assay that measures IL-15 stimulation or inhibition. The IL-15 Bioassay Cells are provided in a C...

The IL-15 Bioassay is a bioluminescent cell-based assay designed to measure IL-15 stimulation or inhibition. The IL-15 Bioassay Cells are provided ...

The IL-15 Bioassay is a bioluminescent cell-based assay designed to measure IL-15 stimulation or inhibition. The IL-15 Bioassay Cells are provided ...

Interleukin-12 (IL-12) was first identified in 1989 in the supernatant of B lymphocytes transformed with Epstein-Barr virus, and named “natural kil...

Interleukin-12 (IL-12) was first identified in 1989 in the supernatant of B lymphocytes transformed with Epstein-Barr virus, and named “natural kil...

Interleukin-12 (IL-12) was first identified in 1989 in the supernatant of B lymphocytes transformed with Epstein-Barr virus, and named “natural kil...

The Glycerol-Glo Assay measures glycerol using the enzymes glycerol kinase and glycerol-3-phosphate dehydrogenase in a coupled reaction scheme that...